Spectrum Pharmaceuticals Inc (was acquised by Assertio Holdings, Inc (NASDAQ:ASRT) on 31/07/2023) (SPPI) Event May 12, 2022, 20:29 UTC 10 1 comments (30% Negative) SPECTRUM PHARMACEUTICALS INC (SPPI) Reports Q2 2022 Financial Results Comment Full text
Imago Biosciences Inc (the company became a subdivision of the company Merck (NYSE: MRK)) (IMGO) Event May 12, 2022, 20:28 UTC 10 1 comments (10% Negative) Imago BioSciences, Inc. (IMGO) Reports Q2 2022 Financial Results Comment Full text
Adicet Bio Inc (ACET) Event May 12, 2022, 20:18 UTC 10 1 comments (30% Negative) Adicet Bio, Inc. (ACET) Reports Q2 2022 Financial Results Comment Full text
Poseida Therapeutics (PSTX) Event May 12, 2022, 20:16 UTC 10 1 comments (75% Positive) Poseida Therapeutics, Inc. (PSTX) Reports Q2 2022 Financial Results Comment Full text
Erasca Inc (ERAS) Event May 12, 2022, 20:12 UTC 11 1 comments (10% Negative) Erasca, Inc. (ERAS) Reports Q2 2022 Financial Results Comment Full text
Nkarta Inc (NKTX) Event May 12, 2022, 20:09 UTC 10 1 comments (10% Negative) Nkarta, Inc. (NKTX) Reports Q2 2022 Financial Results Comment Full text
Kezar Life Sciences Inc (KZR) Event May 12, 2022, 20:08 UTC 10 1 comments (10% Negative) Kezar Life Sciences, Inc. (KZR) Reports Q2 2022 Financial Results Comment Full text
Talaris Therapeutics Inc (TALS) Event May 12, 2022, 20:07 UTC 10 1 comments (10% Negative) TALARIS THERAPEUTICS, INC. (TALS) Announces Delay in results Trials for our pipeline programs Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
Bolt Biotherapeutics Inc (BOLT) Event May 12, 2022, 20:07 UTC 10 1 comments (30% Negative) BOLT BIOTHERAPEUTICS, INC. (BOLT) Reports Q2 2022 Financial Results Comment Full text
Prometheus Biosciences Inc (company is now a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside the United States and Canada) (RXDX) Event May 12, 2022, 20:02 UTC 10 1 comments (10% Negative) PROMETHEUS BIOSCIENCES, INC. (RXDX) Reports Q2 2022 Financial Results Comment Full text